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GPS2 NUCLEAR LOCALIZATION AND TBL1-MEDIATED STABILIZATION 
ARE IMPORTANT IN REGULATING NUCLEAR ENCODED 
MITOCHONDRIAL GENE EXPRESSION 
JIAWEN HUANG 
ABSTRACT 
 G-protein pathway suppressor 2 (GPS2) is a 36kD protein involved in a number 
of regulatory functions in key metabolic organs. First discovered as a suppressor of the 
RAS- and MAPK- signaling pathways, GPS2 is subsequently identified as part of the 
NCoR/SMRT corepressor complex that play an important regulatory role in gene 
transcription, and GPS2 is also involved in meiotic recombination in the nucleus. 
Recently, we identified a non-transcriptional role of GPS2 as an inhibitor of the pro-
inflammatory JNK pathway activation in response to tumor necrosis factor alpha (TNF-
α) in the cytosol. This suggests that GPS2 function may be dependent on its cellular 
localization. However, an understanding of how GPS2 differentially target cellular 
compartments is still lacking. In this study, we show that a tightly controlled balance 
between GPS2 protein stabilization and degradation regulates the function of nuclear 
GPS2. Our results reveal that methylation by arginine methyltransferase PRMT6 and 
interaction with exchange factor TBL1 cooperate to protect GPS2 from Siah2-dependent 
proteasomal degradation, thus promoting GPS2 nuclear localization. In addition, our 
results link GPS2 protein instability to decreased nuclear-encoded mitochondrial gene 
expression, suggesting that GPS2 may play an important role in regulating mitochondrial 
oxidative capacity, whose imbalance has been linked to chronic inflammation and insulin 
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resistance. In conclusion, our findings illustrate post-transcriptional modification is 
important in the regulation of GPS2 cellular function. Understanding such molecular 
regulation of GPS2 is critical in furthering future efforts to investigate its roles in cellular 
homeostasis and inflammatory responses.  
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INTRODUCTION 
Metabolic diseases such as obesity, Type II diabetes mellitus, and insulin 
resistance have been linked to chronically uncontrolled cellular inflammation (Wellen et 
al., 2005; Hotamisligil, 2006). Inflammatory markers such as, TNF-α, are increased in 
obesity and are associated with diminish insulin sensitivity (Hotamisligil, 1993; Uysal et 
al., 1997). G-protein suppressor 2 (GPS2) is a small protein that was originally 
discovered to be involved in the suppression of the RAS- and MAPK- signaling (Spain et 
al., 1996). GPS2 is indicated to have transcriptional regulatory roles through its 
interaction with several transcriptional regulators (Peng et al., 2000, 2001; Lee et al., 
2006; Cheng et al., 2009; Sanyal et al., 2007; Venteclef et al., 2010) and through its 
participation to the NCoR/HDAC3 corepressor complex (Zhang et al., 2002, 2008). In 
addition, our lab recently reported a non-transcriptional role of GPS2 in the cytoplasm via 
the inhibition of JNK activation in response to TNF-α (Cardamone et al., 2012). Our 
findings indicate that both GPS2’s transcriptional and non-transcriptional functions are 
dependent on the inhibition of ubiquitin ligases (Cardamone 2012, 2014). These results, 
together with evidences of the dysregulation of SMRT- and GPS2-mediated inhibition of 
pro-inflammatory genes in human obese adipose tissue (Toubal et al., 2013), define 
GPS2 as a key regulator in the suppression of inflammatory responses in metabolically 
relevant organs. Presently, our lab generated adipose tissue-specific GPS2 KO mice and 
observed obesity-induced upregulation of pro-inflammatory genes and altered lipid 
metabolism in vivo (unpublished data). Despite this emerging important role of GPS2, 
little is known about the endogenous mechanism regulating GPS2 protein stability or 
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degradation and its intracellular localization. Understanding the pathways and 
mechanisms governing the expression of GPS2 protein will be important in 
characterizing the GPS2 KO mice.  
Preliminary results in the lab show that GPS2 is highly unstable unless it is 
complexed with Transducin β-like protein 1 (TBL1), which contains a F-box/WD-40 
repeat, and it is associated with GPS2 in the NCoR/HDAC nuclear receptor corepressor 
complex (Zhang et al., 2002). However, the mechanism by which TBL1 stabilize GPS2 is 
unknown.  It has been reported that phosphorylation, sumoylation, and ubiquitination are 
important in regulating cellular localization and functions for components of the 
NCoR/SMRT complex (Zhang et al., 2005; Choi et al., 2011, 2013; Perissi et al., 2008; 
Huang et al., 2011), therefore we hypothesize post-translational modification could 
similarly regulate the function and expression of GPS2 level (Bi et al., 2014; 
Jarmalavicius et al., 2010; Guo et al., 2014). Also, our previous work has shown the 
mechanism for the dismissal of the NCoR/SMRT corepressor complex depends on 
TBL1/TBLR1-dependent recruitment of Siah2/UbcH5 ubiquitin machinery (Perissi et al., 
2004; Huang et al., 2009; Pascual et al., 2005). Here, we hypothesize that GPS2 protein 
level would be similarly regulated. Our results reveal the existence of a similar but 
distinct strategy with nuclear GPS2 levels being regulated by a fine balance between 
protein degradation and stabilization. GPS2 in the nucleus is readily degraded by E3 
ubiquitin ligase, Siah2. TBL1 stabilizes ubiquitinated GPS2 from proteasomal 
degradation by interaction between both proteins’ N terminal domains. In addition, we 
found that protein arginine methyltransferase 6 (PRMT6) methylates GPS2, which 
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contributes to the stability of the interaction between TBL1 and GPS2, preventing GPS2 
from degradation.  
Once it is stabilized in the nucleus, GPS2 regulates gene expression both as a 
repressor as part of the NCoR/SMRT complex and a coactivator as in the cases of 
LXR/PPAR and other transcription factor. Initial analysis of GPS2 genome wide 
localization in 3T3-L1 identified a subset of genes that are important for regulating lipid 
mobilization (i.e. ATGL/HSL), where GPS2 acts as a pioneer factor for PPARγ 
recruitment (Cardamone, 2014). Here, further analysis of the same data set indicates that 
GPS2 binds to the proximal promoters of a large majority of mitochondrial genes, raising 
the possibility that GPS2 and associated cofactors modulate mitochondrial functions via 
regulation of the expression of the nuclear-encoded subunits of the electron transport 
chains. 
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MATERIALS AND METHODS 
 
Cell Culture 
 
3T3-L1 fibroblasts are maintained in DMEM (Corning, 10-016-CV) with 10% 
BCS (Thermo Scientific) at 37°C and 5% CO2. Hela and HEK293T cell lines are 
maintained in DMEM with 10% FBS (Thermo Scientific) at 37°C and 5% CO2.  
Antibodies, siRNA and Reagents 
 
In this work, commercial antibodies used in the experiments were: Anti-GPS2 
that our lab generated using a peptide representing amino acid 1 to 22, Anti-βtubulin 
(TUB 2.1 clone, Sigma), Anti-HDAC2 (Santa Cruz Biotech sc-9959), Anti-PRMT6 
(A300-929A, Bethyl Labs), Anti-HA-HRP (Roche), Anti-FLAG-HRP (Sigma), Anti-
Siah2 (Santa Cruz Biotech sc-5507). SiRNAs against human TBL1 and PRMT6 and 
siRNA against human and mouse GPS2 were purchased from Ambion. MISSION® 
SiRNA Universal Negative Control (Sigma) is included in each experiment. Cells were 
treated with 10nM MG-132 (InSolution 474791, Calbiochem-EMD) for 4 hour to inhibit 
proteasomal degradation in cells. Cells were treated with 25nM FCCP (Sigma) to 
uncouple respiratory chain. Cells were treated with 10ng/ml TNF-α (Calbiochem) to 
induce inflammatory response.  
Primers Design 
Search for the DNA sequence of gene of interest using Ensembl database. Select 
two exons specific to the gene of interest and choose some regions at the end of the first 
exon and the beginning of the second exon. Paste the selected sequences into the primer 
selection tool, Primer3, and adjust the primer picking conditions as follows:  
	  	  
	  5 
for primer oligo size in bases, minimum: 50, optimum: 150, max: 180; for melting 
temperature in Celsius, minimum: 62, optimum: 65, maximum: 68. After picking the 
forward and reverse primers, the gene sequence is confirmed using the UCSC Genome 
Bioinformatics’ In-Silico PCR in which it uses the paired PCR primers to search for the 
gene against a sequence database.  
RNA Isolation and qPCR Analysis 
Total RNA was isolated by directly lysing cells on the plate adding a highly 
denaturing buffer and the lysate was homogenized through QIAshredder® (RNeasy Plus 
Mini Kit, QIAGEN). The homogenized lysate was centrifuged through gDNA Eliminator 
spin column (QIAGEN). Ethanol was added to provide proper binding condition and the 
sample was transferred to an RNeasy® spin column for binding of total RNA per 
manufacturer’s protocol (QIAGEN). RNA concentration is determined using 
NanoDrop™2000 (Thermo Scientific). cDNA was generated from the isolated total RNA 
using iScript™ Reverse Transcriptase Supermix (Bio-Rad) per manufacturer’s protocol 
using a Veriti® Thermal Cycler (Life Technologies), followed by SYBR® Green qPCR 
amplification on a Viia7™ Real-Time PCR System (Life Technologies). The qPCRs 
were performed on 384-well PCR plates (GeneMate) or 96-well PCR plates (Thermo 
Scientific), with RealTime PCR adhesive films (Danville Scientific). qPCRs were 
performed in triplicate for each sample. All samples were normalized to Cyclophilin A. 
Analysis on the qPCR results was performed in Microsoft Excel.  
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Site Directed Mutagenesis and Bacterial Transformation 
GPS2 mutation of arginine 323 (GPS2-R323A) was performed using QuikChange 
II XL Site-Directed Mutagenesis Kit per manufacturer’s protocol (Agilent Technologies). 
To 50ul–100ul competent bacteria, 10–100pg of mutant DNA was added and mixture 
was kept on ice for 20 minutes. Heat shocked the bacteria at 42°C for 40 seconds, and 
then placed on ice for 2 minutes. Added bacteria to 1ml LB and incubate for 45 mins at 
37°C at 200 rpm. Centrifuged the bacteria at 6000 rpm for 5 minutes, discarded 
supernatant, and plated on LB plates with ampicillin using glass beads. Incubated at 37°C 
at 200 rpm overnight. Next day, picked colonies and grew in LB broth at 37°C at 200 
rpm overnight.  
Mini Prep and Midi Prep 
2mls of bacteria were pelleted for 30 seconds at max speed. Pellet was 
resuspended in 300ul of buffer P1 (Qiagen) and incubated for 5 minutes. Then, it was 
lysed with 300ul of buffer P2 (Qiagen) and inverted 5 times, incubated for 5 minutes. The 
lysate was neutralized with 300ul of buffer P3 (Qiagen), incubated for 5 mins on ice. 
Spun down lysate at full speed for 10 minutes. 800ul supernatant was transferred in to a 
new microcentrifuge tube, added 560ul of isopropanol, and mixed. Spun down the 
mixture for 15 minutes at full speed. Washed the pellet with 300–500ul 70% ethanol and 
spun down at max speed for 5 minutes. Air-dried DNA was resuspended in 40ul of water. 
After confirming the mutation of GPS2 arginine 323 in by sequencing, the plasmid DNA 
is purified by HiSpeed Plasmid Midi Kit (Qiagen).  
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Transient Transfection  
Mammalian cells were grown to about 70% confluence. Transient transfection in 
cells was performed using the Lipofectamine® 2000 per manufacturer’s protocol (Life 
Technologies) with 2μg plasmid DNA and/or with 10nM siRNA. Cells were incubated at 
for 24 hours at 37°C/5% CO2 for transfection of plasmid DNA and for 48 hours for 
transfection of siRNA.  
Protein Extraction and Western Blotting 
To extract fractionated cytosolic and nuclear proteins, cells were washed with 
cold PBS, harvested and spun down for 5 minutes at 1000 rpm (4°C). Cell pellet was 
resuspended in cold hypotonic buffer (10mM Hepes pH 7.9, 1mM EDTA, 210mM 
Mannitol, 70mM sucrose, 0.1mM PMSF, and protease inhibitor mix (Roche), and lysed 
by 10 passages of syringe (26Gx3/8”) homogenization. After precipitating the nuclei by 
2000xg centrifugation for 10 minutes at 4°C, the supernatant containing the cytosolic 
proteins was recovered and the nuclear pellet was lysed for 20 minutes on ice with high 
salt buffer (20mM Tris-HCl pH 8.0, 25% glycerol, 420mM NaCl, 1.5mM MgCl2, 0.2mM 
EDTA, 0.5mM DTT, 0.1mM PMSF, 10mM NEM, and protease inhibitor mix). 
Centrifuged at 20,000xg to remove membrane debris, the supernatant containing the 
nuclear proteins was recovered. Concentration of the fractionated protein extracts were 
measured using the Quick Start™ Bradford 1X Dye Reagent per manufacturer’s protocol 
(Bio-Rad) and the NanoDrop™2000. Fractionated extracts were boiled with NuPAGE 
LDS Sample Buffer-4X (Life Technologies) and DTT at 100°C for 10 minutes. Extracts 
then were loaded onto 10% Mini-PROTEAN® TGX™Gel and separated by 
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electrophoresis with 1x Tris-Glycine-SDS Running Buffer (Boston BioProducts). 
Precision Plus Protein™Dual Color Standards was used as the ladder (Bio-Rad). 
 Proteins were then transferred onto PVDF membranes (EMD Millipore), followed 
by standardized western blotting protocol. Chemiluminescent western blot detection was 
performed using Clarity™ Western ECL Substrate and ChemiDoc™XRS+ with Image 
Lab software per manufacturer’s protocol (Bio-Rad).  
  
	  	  
	  9 
RESULTS 
Interaction with TBL1 via the N-terminal domain of GPS2 is required for its 
nuclear localization and protein stabilization. 
Preliminary experiments in the lab suggested that nuclear localization of GPS2 
was determined by a sequence within the N-terminus. To investigate the molecular 
determinants of GPS2 nuclear localization, HA-tagged GPS2 full length (Wt), its N-
terminus domain (Nt) or the C-terminus domain, were overexpressed in 293T cells. 
Western blot analysis shows that the full length GPS2 protein and the deletant containing 
only the N-terminus domain are both expressed in the nuclear (NE) and cytosolic 
fractioned (CE) extracts, whereas the C-terminus domain is found only in the cytosolic 
fraction (Fig. 1A). This indicates that the N-terminus domain is required for GPS2 
nuclear localization. Unfortunately, further mapping of the N-terminus region could not 
be performed due to protein instability. 
It is known that the N-terminal domain of GPS2 interacts with TBL1 (aa 1–53) 
and promotes the correct assembly of the NCoR/SMRT corepressor complex (aa 53–90) 
(Oberoi, 2011). Therefore, we hypothesize that binding to TBL1 is required for the 
stabilization of GPS2. Indeed, when I downregulate TBL1 via small interfering RNA 
GPS2 expression is decreased (Fig. 1B). My result confirms previous findings that GPS2 
protein expression is decreased when TBL1 is genetically ablated in mouse embryonic 
stem cells (Perissi, 2004). In addition, deletion of amino acids 1-40 from the N-terminus 
of GPS2 leads to decreased expression compared to the wild type and deletion of amino 
acids 1-60 as well as 1-80, which showed no detectable protein expression (unpublished 
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data). These results confirm that TBL1, which interacts with GPS2 1-52, is required for 
GPS2 protein stabilization, and further mapping revealed amino acid 40-60 in the N-
terminus of GPS2 is the minimal nuclear localization domain required for its nuclear 
targeting. Interestingly, prediction analysis indicates the presence of a classic nuclear 
localization sequence (NLS) within this region. However, specific mutation of the NLS 
does not affect GPS2 localization to the nucleus, suggesting that GPS2 is targeted to the 
nucleus via interaction with other nuclear cofactors. 
A       B 
     
Figure 1. Interaction with TBL1 via the N-terminal domain of GPS2 is required for 
nuclear localization and protein stabilization. (A) Western blot analysis of nuclear 
(NE) and cytosolic (CE) extracts from 293T cells transfected with HA-tagged GPS2 HA-
tagged GPS2 wild type (Wt), N-terminus domain (Nt), or C-terminus domain (Ct). Result 
shown is representative of at least two independent experiments. (B) Western blot 
analysis of GPS2 expression in nuclear extracts when TBL1 is downregulated via TBL1-
specific siRNA. Result shown is representative of at least three independent experiments. 
 
 
Ubiquitination of specific lysines in the GPS2 C-terminal domain is required for its 
proteasomal degradation. 
It has been reported that GPS2 instability is due to ubiquitin-dependent 
degradation process (Peng et al., 2001; Cardamone et al., 2012; Bi et al., 2014; Jin et al., 
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1997). While investigating whether GPS2 is destabilized and degraded via proteasomal 
degradation in the absence of TBL1, our unpublished data confirmed that destabilization 
of GPS2 is mediated through poly-ubiquitination-dependent degradation, as shown with 
immunoprecipitation of GPS2 from cells overexpressing HA-tagged ubiquitin or 
untransfected cells. Our preliminary data also suggested that the sites of poly-
ubiquitination are located in the C-terminal domain. To confirm the role of C-terminus in 
regulating GPS2 stability, I performed western blot analysis of HA-GPS2 with 
overexpression of GPS2 with specific mutation of three lysines (K254, 300, 327A) in the 
C-terminal domain compared to wild-type GPS2 (Wt). The result indicates the triple 
mutant shows increased GPS2 stabilization when compared to wild type (Fig. 2A). This 
suggests that these lysines play a degradative function for GPS2. As expected, 
considering the increased expression, the triple lysine mutant (K234, 300, 327A) is also 
slightly more efficient than the wild type in rescuing hyperinflammatory activation by 
specific downregulation of GPS2 (Cardamone, 2012) (Fig. 2B). The results together 
reveal that GPS2 instability is promoted by poly-ubiquitination dependent degradation, 
within the C-terminal domain. 
 
 
 
 
 
 
	  	  
	  12 
A     B 
 
Figure 2. Ubiquitination of specific lysines in the GPS2 C-terminal domain is required 
for its proteasomal degradation. (A) Western blot analysis of HA-GPS2 with site-directed 
mutagenesis of lysine 254, 300, and 327 compared to wild type HA-GPS2. Result shown 
is representative of at least two independent experiments. (B) Gene expression analysis of 
pro-inflammatory target CCL2 activation in 293T cells that are downregulated in GPS2 
via siRNA and rescued by wild type GPS2 or triple lysine mutant (K254,300,327A). 
Result shown is the average of three independent biological experiments. Average of 
each sample within an independent biological experiment is the mean of technical 
triplicates. 
 
GPS2 ubiquitination and degradation by Siah2. 
The next question we wanted to address was which is the ubiquitin ligase 
responsible for GPS2 ubiquitination-dependent degradation. Previous reports by Zhang et 
al. (1998) and our lab have shown that Drosophila seven-in-absentia homolog 2 (Siah2)-
mediated ubiquitination promotes the dismissal of the NCoR/SMRT corepressor complex 
from targeted genes and is necessary for the degradation of NCoR. Since GPS2 is a core 
component of the NCoR/SMRT corepressor complex, we reasoned that Siah2, or the 
highly conserved homolog Siah1, could potentially be responsible for catalyzing the 
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poly-ubiquitination-dependent degradation of GPS2. This hypothesis was validated by 
previous work in the lab, confirming that in 293T cells, endogenous and overexpressed 
GPS2 are significantly downregulated with the overexpression of HA-Siah1 and HA-
Siah2. To further confirm that the effect of the Siah proteins is mediate by the 
ubiquitination of the lysines (K254, 300, 327A) in the C-terminal domain of GPS2, I 
overexpressed Siah1/2 in 293T cell and showed that Siah1/2 prevents the expression of 
the wild type GPS2 construct but it does not induce degradation of GPS2 triple mutant in 
nuclear protein extracts (Fig. 3A). In addition, we were able to obtain adipose tissue 
samples of Siah2 knock out mice (Frew et al., 2003), and I found that that GPS2 protein 
level is significantly higher in the fat of the KO mice compared to that of the wild type 
littermates (Fig. 3B). In conclusion, these data indicate that GPS2 proteasomal 
degradation is mediated by Siah2 dependent poly-ubiquitination of three lysines located 
within GPS2 C-terminus. 	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A           B 
 
Figure 3. Siah2 mediates degradation and ubiquitination of GPS2. (A) Western blot 
analysis of overexpression of Siah1/2 in 293T cells on the expression of GPS2 triple C-
terminal lysine mutant (K254, 300, 327A) and wild type GPS2 in the cytosolic and 
nuclear extracts. Result shown is representative of at least two independent experiments. 
(B) Western blot analysis of GPS2 expression from extracts of Siah2 KO and wild type 
mouse adipose tissues. Result shown is representative of at least two independent 
experiments. 
 
PRMT6-mediated methylation of arginine323 prevents proteasomal-dependent 
degradation of GPS2. 
Interestingly, the three lysines required for GPS2-dependent poly-ubiquitination 
are flanking arginine 323 (R323), which has been recently reported as a site of 
differential demethylation in melanoma cells (Jarmalavicius, 2010). Thus, we 
hypothesized that methylation of R323 could affect GPS2 protein stability and 
degradation. Previous work in our lab has shown that the R323A mutant construct of 
GPS2 that cannot be methylated is highly unstable, unless the expression is rescued by 
inhibiting its degradation via the specific proteasome inhibitor MG132 (unpublished 
data). In addition, the ablation of the methylation site impaired GPS2 binding to TBL1 in 
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immunoprecipitation (unpublished data). Specific motifs, such as WD40 domains like the 
one present in the C-terminus of TBL1, have been reported to possessing selective 
affinity for methylated residues (Migliori, 2012). This suggests that TBL1-mediated 
protective effect against GPS2 degradation might be modulated by post-transcriptional 
modifications.  
In order to further investigate this potential regulatory mechanism, we looked for 
the specific enzymes responsible for R323 methylation of GPS2. Protein arginine N-
methyltransferases (PRMTs) that can catalyze mono-methylation and asymmetric 
demethylation belong to the Type I PRMT family (Zhang and Reinberg, 2006). Although 
PRMT1 is the major source of Type I methyltransferase activity in mammalian cells, 
previous work had eliminated PRMT1 as a candidate enzyme for GPS2 (Jarmalavicius, 
2010). Among the rest of the Type I PRMTs, only PRMT6 is exclusively a nuclear 
enzyme, whereas the others are mainly cytosolic or membrane associated (Bedford, 2009; 
Frankel, 2002; Harrison, 2010; Lee, 2009). Therefore, I downregulated PRMT6 in HeLa 
cells to test whether GPS2 methylation would be impaired. As shown in Figure 4A, 
siPRMT6 transfection leads to significant reduction of GPS2 methylation in the nucleus 
since decrease in methylation subsequently leads to decreased protein level. In addition, 
specific downregulation of PRMT6 in 293T cells results in reduced expression of HA-
tagged GPS2 (Fig. 4B). Importantly, the reduction in protein expression is due to 
proteasomal degradation and not to changes in gene expression as shown in the following 
findings: i) protein expression of HA-tagged GPS2 is rescued with proteasome inhibition 
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by MG132 (Fig. 4B); ii) mRNA expression of endogenous GPS2 is not affected by 
specific downregulation of PRMT6 as measured by RT-qPCR (Fig. 4C).  
A   B 
 
C 
 
Figure 4. GPS2 proteasomal-dependent degradation is prevented by PRMT6 
methylation of Arginine323. (A) Western blot analysis of GPS2 methylation with 
transient transfection of siRNA for PRMT6 in 293T cells. Result shown is representative 
of at least two independent experiments. (B) Western blot analysis of HA-GPS2 
expression with transient transfection of siRNA for PRMT6 in 293T cells with and 
without proteasome inhibitor MG132 treatment. Result shown is representative of at least 
two independent experiments. (C) qPCR analysis of GPS2 mRNA expression in 293T 
cells with downregulation of PRMT6 via specific siRNA. Result shown is the average of 
at least three independent biological experiments. Average of each sample within an 
independent biological experiment is the mean of technical triplicates. 
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Proposed model mechanism of GPS2 regulation.   
Next, our lab set out to investigate whether TBL1 protects GPS2 from 
degradation by preventing its poly-ubiquitination mediated by Siah2. Without TBL1, 
GPS2 is rapidly degraded. This suggests that TBL1 plays a protective role towards GPS2 
in preventing it from degradation. However, using MG132 to inhibit proteasomal 
degradation revealed that GPS2 ubiquitination is still present with downregulation of 
TBL1 (unpublished data). This suggests that Siah2-mediated poly-ubiquitination and 
degradation of GPS2 is independent of the presence of TBL1. Altogether, our results 
indicate that interaction with TBL1 stabilizes GPS2 between the N terminal domains of 
both proteins, and secondary interaction between the C terminal domains via PRMT6-
mediated methylation further promotes GPS2 stability. This interaction prevents GPS2 
proteasomal degradation, but is independent of GPS2 poly-ubiquitination on the C 
terminal domain by Siah2.  
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Figure 5. Proposed model mechanism of GPS2 regulation. (A) TBL1 directly interacts 
with GPS2 via the N terminal domains of both proteins, which is strengthened by the 
interaction between the proteins’ C terminal domains. In addition, GPS2’s stability is 
regulated by PRMT6-mediated methylation to prevent its proteasomal degradation. On 
the other hand, Siah2 promotes GPS2 degradation via poly-ubiquitination on the C-
terminus of the protein. This is independent from the interaction between GPS2 and 
TBL1 and PRMT6-mediated methylation of GPS2.  
 
GPS2 is required for transcriptional regulation of nuclear encoded mitochondrial 
gene in response to cellular perturbation. 
Our lab has previously performed GPS2 chromatin immunoprecipitation 
sequencing (ChIP-seq) in 3T3-L1 cells (Cardamone, 2014). Bioinformatic analysis of this 
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data indicates that GPS2 peaks are localized within the vicinity of a number of nuclear-
encoded mitochondrial genes. Since a majority of mitochondrial genes are nuclear-
encoded (Garesse and Vallejo, 2001), this suggests the possibility that GPS2, along with 
associated cofactors, can potentially modulate mitochondrial functions through regulating 
the expression of nuclear-encoded mitochondrial genes. Because we expect that altering 
the stability and/or the nuclear localization of GPS2 would affect the expression of its 
target genes, including mitochondrial genes, I set out to optimize the conditions to assess 
changes in gene expression in response to FCCP, which is a potent proton ionophore that 
can uncouple ATP synthesis and oxidative phosphorylation of the electron transport 
chain in the mitochondria (MeSH, 2007). First, I performed time course experiments to 
establish the optimal time point that FCCP induces changes in mitochondrial gene 
expression in 3T3-L1 using qPCR. The nuclear-encoded mitochondrial genes of interest 
are presented in Table 1. These genes are targets of GPS2 binding in ChIPseq that were 
selected to represent important mitochondrial function.  
My results indicate that treating 3T3-L1 with FCCP leads to depressed expression 
of these genes after 10 minutes and 30 minutes, which then return to the level comparable 
to the untreated cells after 60 minutes. Subsequently, the gene expressions are reduced 
after 3 hours and 6 hours of FCCP treatment (Fig. 6A). According to these results, we 
chose 30-minute and 3-hour time points for subsequent experiments to test GPS2 
regulation of nuclear-encoded mitochondrial gene transcription in presence of FCCP. As 
shown in Figure 6B, gene expression levels for GPS2 and subunits of complexes I, II, III, 
and V of the electron transport chain are reduced upon FCCP treatment in 293T cells 
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after 30 minutes, then return to initial levels after 3 hours. Downregulation of GPS2 via 
specific siRNA transient transfection leads to significant reduction in gene expression 
levels of complex I and III subunits of electron transport chain. Similar patterns of 
reduction in expression with downregulation of GPS2 are observed in selected genes of 
fatty acid oxidation/synthesis, mitochondrial fusion/fission, and mitochondrial 
anchor/translocase, with the exception of cholesterol synthesis (idi1) and superoxide 
dismutase (sod2) (Fig. 6C, 6D, 6E).  
	  
 
Table 1. Nuclear-encoded mitochondrial genes of interest. 
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DISCUSSION 
GPS2 is involved in a range of important cellular processes, including cell 
division, cell apoptosis, transcriptional regulation, and transduction signaling pathways 
(Spain et al., 1996; Peng et al., 2000, 2001; Lee et al., 2006; Cheng et al., 2009; Sanyal et 
al., 2007; Venteclef et al., 2010). It has been recently identified that GPS2 is linked to the 
regulation of metabolic and inflammatory pathways (Sanyal et al., 2007; Jakobsson et al., 
2009; Cardamone et al., 2012; Toubal et al., 2013; Venteclef et al., 2010). Previous 
reports from our lab indicate that GPS2 participates in these cellular processes due to its 
ability to regulate ubiquitin signaling in different cellular compartments (Cardamone et 
al., 2012, 2014). This suggests that the regulation of GPS2 intracellular localization could 
have an important implication on cellular homeostasis. In this study, we set out to 
identify such mechanism and found that GPS2 nuclear localization depends on a minimal 
nuclear localization domain located at the N-terminus, which is mediated via interaction 
with TBL1 (Fig. 1). 
While investigating the degradative mechanism for GPS2 instability in the 
absence of TBL1, we discovered that GPS2 is poly-ubiquitinated and is subjected to 
proteasomal-dependent degradation (Fig. 2). Interestingly, we identified Drosophila 
seven-in-absentia homolog 2 (Siah2) is responsible for the ubiquitination of GPS2 (Fig. 
3). Siah2 is an E3 ubiquitin ligase that is involved in the ubiquitination of the nuclear 
receptor corepressor NCoR and HDAC3 (Zhang et al., 1998; Zhao et al., 2010), among 
other targets. Our previous work has shown TBL1 is necessary for the ubiquitination and 
the dismissal of the NCoR/SMRT corepressor complex upon gene activation. Based on 
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the above observations and literature, we deduce that TBL1’s F box domain is required 
for the recruitment of Siah2-UbcH5 to the NCoR complex, in a similar fashion to Ebi’s 
regulation of Tramtrack88 in Drosophila and β-catenin in mammalian cells (Perissi et al., 
2004,2008; Dong et al., 1999; Matsuzawa et al., 2001). However, another study reports 
that TBL1 acts to protect β-catenin in Wnt signaling, suggesting that Siah1 can 
independently ubiquitinate β-catenin (Dimitrova et al., 2010). These opposing 
observations pose the question of whether TBL1 acts to promote or prevent poly-
ubiquitination and degradation mediated by Siah2-UbcH5.  Our results indicate that in 
the case of GPS2 TBL1 is not required for Siah-dependent ubiquitination, but rather plays 
a protective role against protein degradation. Further studies are required to address the 
mechanism as to how interaction with TBL1 prevents GPS2 from becoming degraded.  
Lastly, our work identifies arginine methyltransferase PRMT6 as an important 
regulator of GPS2 protein stabilization and finds that the protective effect of TBL1 is 
modulated by post-translational modification of GPS2. The local nuclear environment 
stringently controls this regulatory mechanism. It has been reported that asymmetric 
demethylation of GPS2 occurs on R323 while identifying modifications that are specific 
to human leukocyte antigen peptidome of melanoma cells (Jarmalavicius, 2010), however 
the enzyme that is responsible for the modification of GPS2 is unknown. In our study, 
results indicate that PRMT6 methylation is required for GPS2 protein stabilization 
promoted by TBL1 (Fig. 4). Our data suggests that PRMT6 is the main enzyme that 
methylates and stabilizes GPS2 in the nuclear compartment. However, we cannot exclude 
the possibility that other Type I PRMTs are able to methylate GPS2 in other cellular 
	  	  
	  29 
compartments or in different tissues (Bedford and Clark, 2009). Interestingly, PRMT6 
has been found to be involved in processes that are related to GPS2 functions, such as 
chromatin remodeling, cell cycle regulation, p53 activity, transcriptional regulation by 
NFkB pathway (Di Lorenzo et al., 2014; Kleinschmidt et al., 2012; Stein et al., 2012; 
Neault et al., 2012).  This suggests that some of the effects observed with modulation of 
PRMT6 may be due to changes in GPS2-mediated functions.  
Altogether, while our results confirm that GPS2 directly interacts with TBL1 via 
the N terminal domain of GPS2 (Oberoi et al., 2011), the data also show that the 
methylation of arginine 323 on the C terminal domain may be necessary for promoting a 
stable interaction between GPS2 and TBL1. This may be due to the fact that the WD40 
domain of TBL1 acts as the reader of the methylated arginine on GPS2 (Migliori, 2012). 
In addition, the results indicate that PRMT6 mediates the methylation of GPS2, possibly 
on arginine 323, which prevents its proteasomal-dependent degradation that is regulated 
by Siah2.  
In conclusion, this study elucidates a tightly regulated mechanism that defines 
GPS2 protein level in the nucleus, in which the E3 ubiquitin ligase Siah2 promotes the 
degradation of GPS2 and TBL1 stabilizes the protein in a PRMT6-dependent fashion. 
Our results show the downregulation of GPS2 protein levels in the nucleus directly lead 
to reduce expression of nuclear-encoded mitochondrial genes. This suggests GPS2 might 
play an important role in regulating mitochondrial oxidative capacity, whose imbalance 
has been linked to chronic inflammation and insulin resistance seen in people with Type 
II Diabetes (Patti and Corvera, 2010). 
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